Publicaciones en las que colabora con Jesús García-Foncillas López (16)

2012

  1. The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience

    Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841

2011

  1. Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166

2010

  1. Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab

    Critical Reviews in Oncology/Hematology, Vol. 74, Núm. 3, pp. 193-202

2009

  1. Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer

    Lung Cancer, Vol. 64, Núm. 1, pp. 124-126

  2. Factores ligados a angiogénesis, coagulación y fibrinólisis en el pronóstico de pacientes con cáncer colorectal

    Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 848-854

  3. Primary bone lymphoma of the mandible and thyroid incidentaloma identified by18FDG PET/CT: A case report

    Cases Journal, Vol. 2, Núm. 6

  4. Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin b12 and folic acid supplementation for advanced non-small cell lung cancer

    Onkologie, Vol. 32, Núm. 10, pp. 580-584

2007

  1. Combining chemotherapy and targeted therapies in metastatic colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5867-5876

  2. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What's new?

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5877-5887

2006

  1. New prognostic and predictive factors in advanced colorectal cancer

    Medicina Clinica, Vol. 126, Núm. 14, pp. 541-548

2005

  1. Disnea, oliguria y edema en extremidades inferiores en paciente en tratamiento de radioterapia mediastínica por carcinoma tímico irresecable

    Clinical and Translational Oncology, Vol. 7, Núm. 2, pp. 74-77

  2. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?

    World Journal of Gastroenterology

2004

  1. Angiogénesis y cáncer colorrectal: Papel predictivo y pronóstico del factor de crecimiento del endotelio vascular

    Medicina Clinica

2003

  1. Hemostasia, angiogénesis y cáncer: Papel del factor von Willebrand

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 199-201

  2. Von Willebrand factor as an intermediate between hemostasis and angiogenesis of tumor origin

    Revista de medicina de la Universidad de Navarra, Vol. 47, Núm. 3, pp. 22-28

2002

  1. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160